Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic

• Conditions: Oncology Patients

• Registration Number: NCT04406844
• Lead Sponsor: Max Healthcare Insititute Limited

Brief Summary

In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.

Detailed Description

Protocol No: Onco_Covid-19

Version no:1.0

Objectives: Firstly the patients recently diagnosed with cancer will be selected for enrollment who are on active treatment during lockdown based on the date of their registration in the hospital. This is followed by a telephonic interview with patients or their attendant to carry out a prospective, cross-sectional, observational study in order to address the issues and challenges faced by them during Lockdown.

Collection of data will be done through telephonic communication. Participation in this study will be entirely voluntary. Telephonic verbal consent will be taken from the patients or their attendants before collection of their response on the study questionnaire and then will be asked questions accordingly based on the questionnaire which is available in English and Hindi both. Data and general information regarding participants will only be collected in questionnaire. No personal data of the participants will be taken which will also be conveyed to the participant or attendant during telephonic verbal consent.

Study Timeline

• Study Start: 2020-05-09
• Study First Submitted: 2020-05-25
• Study First Submitted QC: 2020-05-27
• Study First Posted: 2020-05-28
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-20
• Last Update Posted: 2020-07-22
• Primary Completion: 2021-06-30
• Study Completion: 2021-06-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Registered with the Max Institute of Cancer Care between Nov 1st 2019 to Jan 31st 2020
• Were scheduled to receive one or more modalities of treatment (chemotherapy, surgery, radiation therapy, immunotherapy) during the period Feb 1st 2020 to April 30th 2020

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oncology patients	4-8 weeks	To focus on basic issues encountered by oncology patients such as transportation, medical facility, healthcare support, disease apprehension etc

Trial Locations

Locations (1)

Max Superspeciality hospital, A Unit of Balaji Medical and Diagnostic Centre; 🇮🇳 New Delhi, India